HOME >> MEDICINE >> NEWS
Implanted wireless device alerts patients and physicians to dangerous conditions

What if a doctor could keep tabs on a patient's heart failure symptoms on a daily basis, detect-ing subtle increases in weight and blood pressure, the tell-tale signs of worsening heart fail-ure, and summoning the patient to the hospital before they themselves were aware that any-thing was wrong?

More than half a million Americans are diagnosed with heart failure each year, and the condition causes or contributes to 300,000 deaths annually. In addition to being one of the leading causes of death in the U.S., heart failure is the number one cause of hospitalization for people aged 65 and older, it is the most expensive medical condition in the U.S., and its incidence is growing because of the aging population.

Many heart failure patients receive an implanted cardiac resynchronization therapy defibrillator (CRT-D) device upon diagnosis. Now, wireless technology can monitor these devices, along with blood pressure and weight, on a daily basis. The wireless system offers doctors a significant opportunity to better treat heart failure, keep patients out of the hospital and bring them greater peace of mind.

Using Bluetooth technology, Boston Scientific's LATITUDE Patient Management System allows doctors to remotely monitor specific information about the patients' condition to determine if the heart is showing signs of decline. If information is transmitted that suggests something is wrong, the patient's physician can intervene. LATITUDE is the only FDA-approved product for wireless home monitor-ing of a patient's heart condition, implanted device, blood pressure and weight. This wireless cardiac rhythm management system is very new, and many consumers don't realize how important daily monitoring of weight and blood pressure is to detecting early warning signs of worsening heart failure.

Is this something you might be interested in hearing more about? I can arrange interviews for you with cardiologists and patients using this tec
'"/>

Contact: Bill Gray
btgray@webershandwick.com
952-346-6226
Weber Shandwick Worldwide
18-Sep-2006


Page: 1 2

Related medicine news :

1. Implanted medical device aims to lower blood pressure
2. Doctors, engineers develop new wireless system to detect esophageal reflux
3. SCAI highlights study using wireless technology to speed care of heart attack patients
4. New long-distance wireless networking developed at UC Berkeley brings eye care to India
5. Chinese children with hearing devices benefit from new speech test
6. Miniature implanted devices could treat epilepsy, glaucoma
7. Home health care devices focus of FDA Conference at UH
8. Innovative device to treat brain cancer shows promise in early studies
9. New device for stroke patients improves walking
10. UPMC begins study of heart support device as a bridge to transplantation
11. Smokeless cannabis delivery device efficient and less toxic

Post Your Comments:
(Date:4/23/2014)... "simple and accessible detection methods that can rapidly ... of a single cell inside that population has ... Chang Lu. , In the Royal Society of ... announced that he and his coworkers have developed ... of a protein ( Chem. Sci. , 2014, ...
(Date:4/23/2014)... are often displayed in the popular Swedish children,s ... of high-sugar foods. A new study from the ... in children,s TV programmes as well as the ... and weight status. , Steingerdur Olafsdottir,s doctoral thesis ... popular Swedish children,s TV show Bolibompa. Healthy foods ...
(Date:4/23/2014)... led by a researcher from the Cancer Science Institute ... Singapore has identified the cancer specific stem cell which ... of developing new drugs for the treatment of this ... group, led by Dr Chan Shing Leng, Research Assistant ... that a cancer-specific variant of a cell surface protein, ...
(Date:4/23/2014)... in the journal Oncotarget , explored tumour ... or their own DNA signatures within the same ... design effective, targeted treatment strategies. , Firstly they ... and either the KRAS or BRAF mutation. Secondly, ... EGFR gene mutation have that specific mutation present ...
(Date:4/23/2014)... Alzheimer,s disease has been a rapidly evolving pursuit ... latest crook in the research road, scientists have ... proteins associated with the disease. The report, which ... , could have important implications for developing novel ... colleagues explain that for years, research has suggested ...
Breaking Medicine News(10 mins):Health News:Following a protein's travel inside cells is key to improving patient monitoring, drug development 2Health News:High-calorie and low-nutrient foods in kids' TV 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 3Health News:Non-uniform genetic mutations identified in lung cancers could lead to targeted treatment 2
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com announces ... available in its catalogue: ... Forecast and Market Analysis to 2022 ... Atopic Dermatitis - India Drug Forecast and ...
(Date:1/15/2014)... , Jan. 15, 2014  Zafgen, Inc., a ... needs of severely obese patients, today announced initial ... a selective inhibitor of methionine aminopeptidase 2 (MetAP2), ... form of genetic obesity.  These results showed improvements ...
(Date:1/14/2014)... InformEx, North America,s leading business partnering ... the 30 th edition of its annual conference at ... January 21-24. (Logo: http://photos.prnewswire.com/prnh/20131028/NY05330LOGO-a ) ... and specialty chemical companies will take part in the conference, ...
Breaking Medicine Technology:PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2
Cached News: